首页> 中文期刊> 《中国感染控制杂志》 >中国HIV感染者/AIDS患者服用抗病毒治疗药物后耐药性的系统综述

中国HIV感染者/AIDS患者服用抗病毒治疗药物后耐药性的系统综述

         

摘要

Objective To understand drug resistance in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome (HIV/AIDS)after antiretroviral therapy(ART).Methods Articles about drug resistance in HIV/AIDS patients after ART were retrieved from Wangfang data,China National Knowledge Infrastructure(CNKI),and PubMed. Meta analysis were performed.Results 15 articles (1 English and 14 Chinese) were extracted,quality score of 3,4,and 8 articles was 6,7,and 8 respectively. Heterogeneity of the included stud-ies showed the difference was significant (Q= 45.98,P<0.001),there was heterogeneity,random-effects models was conducted for Meta analysis,which revealed that the overall drug resistance rate in HIV/AIDS patients in China was 4% (4% -5% );Begg's test showed that P= 0.012,there was publication bias. After articles were excluded through sensitivity analysis,the combined effect was still 4% (4% -5% ).Conclusion The overall drug resistance rate in Chinese HIV/AIDS patients after ART is not high.%目的 了解接受抗病毒治疗(ART)后,人类免疫缺陷病毒(HIV)感染者/艾滋病(AIDS)患者耐药性.方法 检索中国知网,万方数据资源系统和PubMed数据库,收集中国HIV感染者/AIDS患者ART后耐药性相关文献,进行Meta分析.结果 最终纳入15篇文献(1篇英文和14篇中文),其中3篇质量评分6分,4篇为7分,8篇为8分.异质性检验显示,差异有统计学意义(Q=45.98,P<0.001),存在异质性,所以采用随机效应模型进行Meta分析,结果显示中国HIV感染者/AIDS患者ART后总耐药率为4%(4%~5%).Begg's检验P=0.012,说明存在发表偏倚.通过敏感度分析删除文献后,合并效应量仍为4%(4%~5%).结论 中国HIV感染者/AIDS患者经ART后总耐药率不高.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号